Genetic susceptibility in sepsis: implications for the pediatric population [0.03%]
脓毒症的遗传易感性——儿科病人的影响
Simon Nadel
Simon Nadel
Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients [0.03%]
艾利哌唑：治疗6～17岁自闭症相关易激惹症状患者的疗效及安全性
Monique P Curran
Monique P Curran
Aripiprazole is an atypical antipsychotic approved for the treatment of irritability associated with autistic disorder in pediatric patients aged 6-17 years. In two, randomized, double-blind, placebo-controlled studies in pediatric patients...
Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges [0.03%]
儿科HIV感染患者的抗逆转录病毒药物：药代动力学和实际应用挑战
B Ryan Phelps,Natella Rakhmanina
B Ryan Phelps
Antiretroviral (ARV) therapy has been shown to achieve high therapeutic efficacy in treating pediatric HIV disease. The delivery of affordable, child friendly, and easy to store and administer ARV drugs is key to the successful management o...
Juvenile idiopathic arthritis: new insights into classification, measures of outcome, and pharmacotherapy [0.03%]
儿童特发性关节炎的分类、疗效评定和药物治疗的新进展
Michael W Beresford
Michael W Beresford
Significant advances have taken place in recent years in our understanding of the aetiopathogenesis, management, and clinical outcome of juvenile idiopathic arthritis (JIA). Fundamental to this advancement has been international collaborati...
Navdeep S Nayyar,William McGhee,Dolly Martin et al.
Navdeep S Nayyar et al.
This review summarizes the outcomes and known adverse effects of current immunosuppression strategies in use in pediatric intestinal transplantation. Intestinal transplantation has evolved from an experimental therapy to a highly successful...
Targeting airway inflammation in cystic fibrosis in children: past, present, and future [0.03%]
儿童囊性纤维化气道炎症的靶向治疗：过去、现在和未来
Tacjana Pressler
Tacjana Pressler
Inflammation is a major component of the vicious cycle characterizing cystic fibrosis (CF) pulmonary disease. If untreated, this inflammatory process irreversibly damages the airways, leading to bronchiectasis and ultimately respiratory fai...
Better medicines for 300 million children in China: report on recent progress [0.03%]
更好的药物供中国的3亿儿童使用：执行报告
Zhiping Li,Li Wang,Yi Wang et al.
Zhiping Li et al.
Andy Gray
Andy Gray
Folate fortification and survival of children with acute lymphoblastic leukemia [0.03%]
叶酸强化与急性淋巴细胞白血病儿童的生存率
Deborah A Kennedy,Sandy Grupp,Mark Greenberg et al.
Deborah A Kennedy et al.
Background: The antifolate drug methotrexate is a mainstay of treatment for children diagnosed with acute lymphoblastic leukemia (ALL). There have been concerns regarding the impact of folate fortification on the efficacy...
Spotlight on Tdap₅ vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged ≥4 years), adolescents, and adults [0.03%]
Tdap₅疫苗（科瓦克斯®）作为破伤风、白喉和百日咳单一加强免疫制剂的亮点：用于4岁及以上儿童、青少年和成人接种以预防相应疾病
Lesley J Scott
Lesley J Scott
Covaxis® (also licensed as Triaxis® or Adacel® in individual countries) is a Tdap₅ (i.e. combined tetanus toxoid, reduced diphtheria toxoid, five component acellular pertussis [namely detoxified pertussis toxin, filamentous hemagglutini...